Dr. Cillian De Gascun:

I agree with that sentiment and this comes back to something that Deputy Boyd Barrett said earlier concerning investment in research. South Korea was in a position to act in the way it did very early on because investment had been put in place after the country's experience with SARS in 2002 and MERS in 2012. From our perspective, we had to react in an emergency setting to the emergence of SARS-CoV-2. We had to put in place what Paul Reid termed a wartime structure of sampling and public health contact tracing. We had to put that in place, in part, for a variety of reasons and, not apportioning criticism, there has been underinvestment in our public structures over several years.